Posted on 7/23/19
BostonGene Announces Partnership with National Institutes of Health
WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene Corporation (BostonGene), a biomedical software company, today announced its partnership with the National Institutes of Health (NIH) including the National Cancer Institute (NCI) . . .
Posted on 7/23/19
Samus Therapeutics Launches PU-AD Clinical Program in Alzheimer's Disease
Samus Therapeutics, Inc. today announced the initiation of its clinical program for PU-AD, an oral, brain permeable inhibitor of epichaperomes in Alzheimer's Disease (AD) following clearance . . .
Posted on 7/23/19
Frequency Therapeutics Completes $62 Million Series C Financing
Frequency Therapeutics, a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range
Posted on 7/23/19
Ra Pharmaceuticals Proposes Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ra Pharmaceuticals, Inc. (Nasdaq: RARX) today announced that it intends to offer and sell, subject to market and other conditions, $100 million of its . . .
Posted on 7/22/19
Harvard Bioscience Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
HOLLISTON, Mass., July 19, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that in connection with Michael Rossi being named Chief Financial Officer . . .
Posted on 7/21/19
AVROBIO Closes Underwritten Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc. (NASDAQ: AVRO), a Phase 2 clinical-stage gene therapy company, today announced the closing of its previously announced underwritten public offering of 7,475,000 . . .
Posted on 7/18/19
Fulcrum Therapeutics Prices IPO
CAMBRIDGE, Mass., July 17, 2019 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq:FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined . . .
Posted on 7/18/19
Corindus Adds Two New CorPath GRX Installations to HCA Healthcare Facilities
WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that it has installed CorPath GRX Systems in two . . .
Posted on 7/18/19
NeuroMetrix Reports Q2 2019 Financial Results
WALTHAM, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended June 30, 2019.The Company . . .
Posted on 7/18/19
Bioasis Announces Stock Option Grants
GUILFORD, Conn.--(BUSINESS WIRE)--Bioasis Technologies Inc. (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for the delivery of therapeutics across the . . .
Posted on 7/17/19
Cigna and Express Scripts Named Best Places to Work for Disability Inclusion
BLOOMFIELD, Conn.--(BUSINESS WIRE)--Global health service company Cigna and its Express Scripts business were both named as a Best Place to Work for Disability Inclusion after earning . . .
Posted on 7/17/19
Tufts Health Plan Named a Best Place to Work for Disability Inclusion
Tufts Health Plan been rated a Best Place to Work by Disability: IN on its 2019 Disability Equality Index. This is the second year in a . . .
Posted on 7/17/19
Pandion Therapeutics Appoints Rahul Kakkar as CEO
Pandion Therapeutics, Inc., a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation for autoimmune diseases
Posted on 7/17/19
Orum Therapeutics Announces $30 Million Series B
Orum Therapeutics announced today an oversubscribed $30 million Series B financing. New investors, IMM Investment, Smilegate Investment, KTB Network, and Stassets Investment,
Posted on 7/17/19
Astellas and Frequency Therapeutics Enter into License Agreement for FX-322
TOKYO & WOBURN, Mass.--(BUSINESS WIRE)--Astellas Pharma Inc. and Frequency Therapeutics, Inc. today announced that they have entered into an exclusive license agreement to develop and commercialize . . .
Posted on 7/17/19
ImmunoGen: Bold Move To Position A Comeback
SummaryDue to market unpopularity, turnaround stocks often trade at deep bargains. As such, turnaround equities epitomize fruits in the promised land of mega profits.Amid the failure . . .
Posted on 7/17/19
Cara Therapeutics: Wait For A Better Entry Opportunity
SummaryCara's stock has risen over 100% YTD and 30% over the Last Month.Cara has a strong pipeline, making it an attractive long term investment at lower . . .
Posted on 7/17/19
AVROBIO Prices Underwritten Public Offering of $120.25 Million of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc. (NASDAQ: AVRO), a Phase 2 clinical-stage gene therapy company, today announced the pricing of an underwritten public offering of 6,500,000 shares of . . .
Posted on 7/16/19
HealthBanks Partners with athenahealth's Marketplace Program
HealthBanks, Inc., a provider of Patient Engagement solutions for ambulatory practices and health systems today announced a partnership with athenahealth, Inc. through athenahealth's Marketplace program. As . . .
Posted on 7/16/19
Skyhawk Therapeutics Announces Agreement with Genentech
Skyhawk Therapeutics, Inc. (Skyhawk) today announced that it has entered into a multi-target exclusive option and license agreement with Genentech, a member of the Roche Group, . . .
Posted on 7/16/19
Ra Pharmaceuticals and Camurus Announce Exclusive License Agreement
CAMBRIDGE, Mass. & LUND, Sweden--(BUSINESS WIRE)--Ra Pharmaceuticals, Inc. (Nasdaq:RARX) and Camurus AB (Nasdaq STO:CAMX) today announced an exclusive worldwide license agreement for the use of Camurus’s . . .
Posted on 7/15/19
Boston Children’s Hospital Forms Strategic Partnership with Premier
CHARLOTTE, N.C.--(BUSINESS WIRE)--Boston Children’s Hospital, one of the largest pediatric medical centers in the U.S., has partnered with Premier Inc. (NASDAQ: PINC), a leading healthcare improvement . . .
Posted on 7/15/19
Nine Tech Startups Vie for Partnerships & Scale in MetLife’s Intensive 13-week Business ‘Boot Camp’
NEW YORK--(BUSINESS WIRE)--MetLife today announced its second class of nine companies selected to participate in the MetLife Digital Accelerator powered by Techstars. Based in the newly . . .
Posted on 7/15/19
Poxel Provides Corporate Update
LYON, France--(BUSINESS WIRE)--POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes . . .
Posted on 7/15/19
KalVista Pharmaceuticals Provides Operational Update
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease . . .

